Voglitor R 0.5/0.3 Tablet

Przegląd produktu

About Voglitor R 0.5/0.3 Tablet

Voglitor R 0.5/0.3 Tablet is a medication containing the active ingredient Repaglinide, classified as Glinide. Repaglinide is an antidiabetic drug in the class of medications known as meglitinides, and was invented in 1983. Repaglinide is a medication used in addition to diet and exercise for blood sugar control in type 2 diabetes.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2.
• Used for: Limitation of Use: Repaglinide tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis
• Use only as directed on the product label or by a healthcare professional.

Active Ingredient & Action

Repaglinide, the active ingredient in Voglitor R 0.5/0.3 Tablet, belongs to the Glinide class. 1 INDICATIONS AND USAGE Repaglinide tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitation of Use: Repaglinide tablets should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Voglitor R 0.5/0.3 Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Voglitor R 0.5/0.3 Tablet for extended periods without medical advice.